Form 4: CEL SCI CORP: Officer Acquires Shares

CEL SCI CORP reports that Chief Scientific Officer Eyal Talor acquired 2,307 shares of common stock on June 30, 2026.

Summary

• Eyal Talor, Chief Scientific Officer of CEL SCI CORP, acquired 2,307 shares of common stock on June 30, 2026.
• The acquisition was made at a price of $1.04 per share.
• Following this transaction, Mr. Talor beneficially owns 9,318 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction without providing new financial or strategic information.

Positives

• Insider buying can signal confidence in the company's future prospects.
• The acquisition of 2,307 shares by a key executive indicates a personal investment in the company's value.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this stock acquisition by a Chief Scientific Officer, are often closely watched by investors as they can provide insights into management's perception of the company's valuation and future performance within the biotechnology or pharmaceutical sector.

Stakeholder Impact

• Shareholders may view insider buying positively, potentially signaling confidence in the company's stock value.

Key Dates

Keywords

CEL SCI CORP, CVM, Form 4, Insider Trading, Stock Acquisition, Eyal Talor, Chief Scientific Officer